GBE Stock Overview
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Genus plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£19.20 |
| 52 Week High | UK£31.26 |
| 52 Week Low | UK£18.71 |
| Beta | 0.31 |
| 1 Month Change | -4.38% |
| 3 Month Change | -28.94% |
| 1 Year Change | -36.00% |
| 3 Year Change | -66.61% |
| 5 Year Change | -32.01% |
| Change since IPO | 51.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| GBE | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | -4.0% | -1.2% | 1.7% |
| 1Y | -36.0% | -23.0% | 2.3% |
Return vs Industry: GBE underperformed the German Biotechs industry which returned -23% over the past year.
Return vs Market: GBE underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| GBE volatility | |
|---|---|
| GBE Average Weekly Movement | 7.2% |
| Biotechs Industry Average Movement | 5.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: GBE's share price has been volatile over the past 3 months.
Volatility Over Time: GBE's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 3,500 | JK Kokke | www.genusplc.com |
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Genus plc Fundamentals Summary
| GBE fundamental statistics | |
|---|---|
| Market cap | €1.30b |
| Earnings (TTM) | €38.96m |
| Revenue (TTM) | €785.18m |
33.4x
P/E Ratio1.7x
P/S RatioIs GBE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GBE income statement (TTM) | |
|---|---|
| Revenue | UK£673.10m |
| Cost of Revenue | UK£429.10m |
| Gross Profit | UK£244.00m |
| Other Expenses | UK£210.60m |
| Earnings | UK£33.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 05, 2024
| Earnings per share (EPS) | 0.51 |
| Gross Margin | 36.25% |
| Net Profit Margin | 4.96% |
| Debt/Equity Ratio | 40.7% |
How did GBE perform over the long term?
See historical performance and comparison